| Date | Description |
| 31 January 2012 | Merck/MSD Animal Health Headquarters in New Jersey, USBoxmeer (the Netherlands), January 31, 2012 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, today announced that it intends to centralize certain functions at the ... |
| 24 January 2012 | Merck Animal Health Enters Public-Private Partnership to Develop Innovative Strategies to Complement Bovine Mastitis TreatmentFocus on Development of Vaccines Against Evasion MoleculesBOXMEER (The Netherlands), January 24, 2012 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announces that ... |
| 13 December 2011 | New Single Shot Vaccine Protects rabbits Against Myxomatosis and Rabbit Hemorrhagic Disease (RHD)BOXMEER (The Netherlands), December 13, 2011 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) is launching NOBIVAC® Myxo-RHD in the European Union, the first single shot vaccine ... |
| 30 November 2011 | Merck Animal Health Launches AQUAVAC Strep Sa for Fighting Streptococcosis in Tilapia, Other SpeciesBOXMEER (The Netherlands), November 30, 2011 — Merck Animal Health (known as MSD Animal Health outside the USA and Canada) has obtained regulatory approval in Brazil to begin marketing AQUAVAC® Strep ... |
| 18 November 2011 | Global Animal Management Launches eyeD Equine Identification SystemBOXMEER (The Netherlands), November 18, 2011 – Global Animal Management, a wholly-owned subsidiary of Merck Animal Health (known as MSD Animal Health outside the USA and Canada), introduced this week ... |
| 7 November 2011 | Swine Dewormer PANACUR AquaSol Receives Positive Opinion in the European UnionBOXMEER (Netherlands), November 7, 2011 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) announced today that it has received positive opinion from the CVMP in the European ... |
| 26 October 2011 | Merck Animal Health Launches EXPERTIS Udder Health, a Farm Management Tool for Veterinarians to Improve Udder Health in Dairy CattleBOXMEER (Netherlands), October 26, 2011 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) has launched EXPERTIS® Udder Health, an innovative farm management tool for veterinarians ... |
| 25 October 2011 | Merck Animal Health Announces European Union Approval for PORCILIS M Hyo ID ONCE Swine VaccineBOXMEER (Netherlands), October 25, 2011 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced that it has received marketing authorization in the European Union ... |
| 22 September 2011 | Merck Animal Health Debuts new Look, Focuses on Science at International Poultry CongressesBOXMEER, The Netherlands, September 22, 2011 — Merck Animal Health (MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, used eye-catching exhibits ... |
| 15 September 2011 | Candidate Vaccine Against Deadly Pneumonia in FoalsBOXMEER (The Netherlands), September 15, 2011 - Rhodococcus equi bacteria can cause “rattles”, a potentially lethal disease in foals which is characterized by pneumonia and gastro-intestinal infection. ... |
| 7 September 2011 | Merck Animal Health Introduces ZUPREVO for Treatment, Prevention of Bovine Respiratory DiseaseBOXMEER, the Netherlands, September 7, 2011 – Merck Animal Health today announced the official launch of ZUPREVO® (tildipirosin) — a novel macrolide antibiotic for the management of bovine respiratory ... |
| 25 August 2011 | Merck Animal Health Expands Vaccine Manufacturing Unit at Elkhorn Biotechnology Excellence CenterELKHORN, NE, United States, August 25, 2011 – Merck Animal Health (MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, has opened today an expansion ... |
| 23 August 2011 | Merck Appoints Richard R. DeLuca Jr. as President, Merck Animal HealthFormer Becton Dickinson and Wyeth Executive Joins MerckWHITEHOUSE STATION, N.J. – August 23, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment ... |
| 10 August 2011 | Merck Animal Health Supports Recovery of the Japanese Animal SectorBOXMEER, the Netherlands, August 10, 2011 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, announced today that ... |
| 28 July 2011 | Dieter Lütticken Award 2010 Granted to Hans-Peter Ottiger for Alternative Purity Test for Avian VaccinesBOXMEER, the Netherlands, July 28, 2011 – Merck Animal Health, formerly known as Intervet/Schering-Plough Animal Health, announced today that the Dieter Lütticken Award 2010, an international annual award ... |
| 20 July 2011 | Merck Animal Health Breaks Ground for $18 Million Vaccine Plant ExpansionBOXMEER, the Netherlands, July 20, 2011 – Merck Animal Health, formerly known as Intervet/Schering-Plough Animal Health, announced today that it has embarked on the expansion of a vaccine manufacturing ... |
| 29 June 2011 | Merck Announces New Name for its Animal Health DivisionBOXMEER, the Netherlands, June 29, 2011 – Merck’s (NYSE: MRK) animal health division, formerly known as Intervet/Schering-Plough Animal Health, announced that effective today it will begin using the new ... |
| 16 June 2011 | European approval for intramuscular administration route of NUFLOR MinidoseBOXMEER (the Netherlands), June 16, 2011 – Intervet/Schering-Plough Animal Health announced today that it has recently received approval via the decentralized procedure in the European Union for the intramuscular ... |
| 14 June 2011 | BacuCheck ELISA test checks PORCILIS PCV vaccination comlianceBOXMEER (the Netherlands), June 14, 2011 – Intervet/Schering-Plough Animal Health has introduced BacuCheck™, a simple ELISA test for confirmation of vaccination status with PORCILIS® PCV of piglets against ... |
| 11 May 2011 | Improved vaccine against progressive atrophic rhinitis in swine launched by Intervet/Schering-Plough Animal HealthBoxmeer (the Netherlands), May 11, 2011 – Intervet/Schering-Plough Animal Health announces today that it is introducing PORCILIS® AR-T DF, an inactivated vaccine against progressive atrophic rhinitis ... |
| 12 April 2011 | Field study confirms protection of piglets against porcine circovirus-associated disease by vaccination with PORCILIS PCVBoxmeer (the Netherlands), April 12, 2011 – Intervet/Schering-Plough Animal Health announces today that a field trial with the single-dose subunit vaccine PORCILIS® PCV has confirmed that vaccination ... |
| 22 March 2011 | Merck and sanofi-aventis to maintain separate businesses in animal healthWhitehouse Station, NJ and Paris, France - March 22, 2011 - Merck (NYSE: MRK) and sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the mutual termination of their agreement to form a new animal ... |
| 4 March 2011 | Intervet/Schering-Plough Animal Health completes delivery of 12 million doses of foot-and-mouth disease vaccine to the government of South KoreaBoxmeer (the Netherlands), March 4, 2011 – Intervet/Schering-Plough Animal Health announces today that it has shipped 12 million doses of foot-and-mouth disease (FMD) vaccine to South Korea to assist ... |
| 15 February 2011 | Intervet/Schering-Plough Animal Health grants rights to pancreas disease vaccine patent portfolioBOXMEER (The Netherlands), February 15, 2011 — Intervet/Schering-Plough Animal Health has granted Novartis Animal Health exclusive rights to part of its patent portfolio for pancreas disease (PD) vaccines.The ... |
| 27 January 2011 | Candidate vaccine against Rhodococcus equi infections in foals to be investigated in field trial in GermanyBoxmeer (the Netherlands), January 27, 2011 – Intervet/Schering-Plough Animal Health announces today that it is entering the final stage of development of a vaccine against Rhodococcus equi, a bacteria ... |
| 30 November 2010 | Novel single-dose broad-spectrum dog dewormer demonstrates good efficacy and is readily consumedBoxmeer (the Netherlands), November 30, 2010 – The broad-spectrum anthelmintic combination preparation for dogs PLERION® (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious ... |
| 11 November 2010 | Studio Bovine to webcast from World Buiatrics Conference 2010 in Santiago de ChileBoxmeer (the Netherlands), October 11, 2010 – Studio Bovine, an intitiative of Intervet/Schering-Plough Animal Health, has recently been launched in order to webcast via a dedicated online TV channel ... |
| 9 November 2010 | Intervet/Schering-Plough Animal Health expands veterinary vaccine manufacturing facility at Biosciences Center BoxmeerBoxmeer (the Netherlands), November 9, 2010 – Today, Intervet/Schering-Plough Animal Health announced that it has opened a specialized filling and freeze-drying unit for veterinary vaccines at its Biosciences ... |
| 4 October 2010 | New canine ear infection treatment combines three powerful agents in once-a-day therapyBOXMEER (The Netherlands), October 4, 2010 – A new once-a-day treatment for otitis externa (inflammation of the outer ear and ear canal) in dogs is now available from Intervet/Schering-Plough Animal Health, ... |
| 30 September 2010 | Intervet/Schering-Plough Animal Health sponsors Equine Business Management Strategies programBOXMEER (The Netherlands), September 30, 2010 – Intervet/Schering-Plough Animal Health announced today that it has entered into an agreement to sponsor the Equine Business Management Strategies (EBMS) ... |
| 27 July 2010 | Sanofi-aventis and Merck appoint Raul Kohan as CEO for the new Animal Health joint ventureParis, France and Whitehouse Station, NJ – July 27, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Merck & Co., Inc. (NYSE: MRK) announced today that Raul E. Kohan will be appointed Chief ... |
| 22 July 2010 | Intervet/Schering-Plough Animal Health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swineSimultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and ... |
| 23 June 2010 | Deltamethrin-impregnated collar provides a cost-effective solution to control canine and human LeishmaniasisBOXMEER (The Netherlands) June 23, 2010 - Delegates at the 2nd International Congress on Canine Leishmaniasis, which was recently held in the Italian city of Pisa, heard how a readily-available deltamethrin-impregnated ... |
| 22 June 2010 | Intervet/Schering-Plough Animal Health receives positive opinion in Europe for simultaneous use of PORCILIS PRRS and PORCILIS M Hyo vaccines in pigletsBOXMEER (the Netherlands), June 22, 2010 – Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency ... |
| 9 June 2010 | Dieter Lütticken Award 2009 for development of in vitro bovine respiratory tract organ culture modelBOXMEER (Netherlands), June 9, 2010 – The Dieter Lütticken Award 2009, a prestigious international annual award dedicated to alternatives in animal testing for veterinary medicines, goes to Dr. A.W. (Dan) ... |
| 1 June 2010 | Equine strangles vaccine returns to the market in EuropeBOXMEER (the Netherlands), June 1, 2010 – Intervet/Schering-Plough Animal Health, the European market leader in equine vaccines, today announces that it is re-introducing EQUILIS® StrepE, the only strangles ... |
| 27 May 2010 | Study shows cost-effectiveness of RESFLOR in feedlot cattle treated for undifferentiated fever related to Bovine Respiratory DiseaseBOXMEER (Netherlands), May 27, 2010 – In a Canadian field trial in feedlot cattle recently published in Veterinary Therapeutics, it was demonstrated that treatment of undifferentiated fever related to ... |
| 10 May 2010 | Intervet/Schering-Plough Animal Health introduces the SLICE Sustainability Project at Sea Lice 2010BOXMEER (The Netherlands), May 10, 2010 — Intervet/Schering-Plough Animal Health has introduced the SLICE® Sustainability Project, a comprehensive, six-step integrated strategy to help the world’s salmon ... |
| 29 April 2010 | Pancreatic disease vaccine patent of Intervet/Schering-Plough Animal Health upheld by Oslo District CourtBOXMEER (Netherlands) and OSLO (Norway), April 29, 2010 – Intervet/Schering-Plough Animal Health announces today that the Oslo District Court has ruled that its Pancreatic Disease (PD) patent NO 317.547 ... |
| 22 April 2010 | Intervet/Schering-Plough Animal Health opens state-of-the-art vaccine manufacturing facility at Biosciences Center BoxmeerBOXMEER (Netherlands), April 22, 2010 – Intervet/Schering-Plough Animal Health announces that it will open today a state-of-the-art production center for veterinary vaccines against bacterial infections. ... |
| 1 April 2010 | Consortium receives research grant from the Wellcome Trust to develop improved vaccines against foot-and-mouth diseaseBOXMEER (Netherlands), April 1, 2010 – An international collaborative group of research institutions and industry today announces that it has received approximately US$ 2 million from the Wellcome Trust ... |
| 19 March 2010 | Broadcasting website offers dairy professionals virtual presence at international mastitis conference in New ZealandBoxmeer, March 19, 2010 - Intervet/Schering-Plough Animal Health launches the website Studio Recharge, broadcasting to the global dairy community from the 5th International Dairy Federation (IDF) Mastitis ... |
| 9 March 2010 | Sanofi-aventis and Merck to create a Global Leader in Animal HealthSanofi-aventis exercises its option to combine Merial with Intervet/Schering-Plough in a new equally-owned Joint Venture with MerckParis, France and Whitehouse Station, NJ. – March 9, 2010 – Sanofi-aventis ... |
| 27 January 2010 | Intestinal Health Center for Poultry website offers rich content, dynamic featuresBOXMEER (Netherlands), January 27, 2010 – Intervet/Schering-Plough Animal Health has launched the Intestinal Health Center for Poultry website (www.ihc-poultry.com), a dedicated website to keep producers, ... |
| 26 January 2010 | Intervet/Schering-Plough Animal Health receives European approval for a single-shot dosage scheme of PORCILIS PCVBOXMEER (Netherlands), January 26, 2010 – Intervet/Schering-Plough Animal Health today announces that it has received marketing authorization from the European Commission on January 12, 2010 for a single-shot ... |
| 13 January 2010 | Symposium shows importance of managing Bovine Respiratory Disease 'right first time' with combination treatmentBOXMEER (Netherlands), January 13, 2010 – Treatment of Bovine Respiratory Disease (BRD) in cattle with a combination preparation consisting of the anti-infective drug florfenicol and the anti-inflammatory ... |
